REFERENCE
Ortho Biotech Inc.Ontario Government Announces Reimbursement of Velcade* As First-Line Treatment For Newly-diagnosed Blood Cancer Patients. Media Release: 13 May 2009. Available from: URL: http://www.orthobiotech.com
Rights and permissions
About this article
Cite this article
Patients newly diagnosed with multiple myeloma in Ontario, Canada, will have access to funding for treatment with bortezomib. Pharmacoecon. Outcomes News 579, 14 (2009). https://doi.org/10.2165/00151234-200905790-00036
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905790-00036